Su, Weiheng
Seymour, Leonard W.
Cawood, Ryan
Funding for this research was provided by:
Biotechnology and Biological Sciences Research Council
Article History
Received: 14 September 2023
Accepted: 30 November 2023
First Online: 7 December 2023
Competing interests
: The authors declare the following competing interests. W.S. is an employee of OXGENE. OXGENE is a company pursuing the development of TESSA for the commercial manufacture of rAAV. W.S., L.W.S. and R.C. are inventors on intellectual property related to this work. W.S. and R.C. are named inventors for patent application filed on the subject matter of this manuscript (PCT/GB2021/050237).